Is Gohealth undervalued or overvalued?
As of 2025-03-22, the Intrinsic Value of Gohealth Inc (GOCO) is 19.53 USD. This Gohealth valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 13.74 USD, the upside of Gohealth Inc is 42.10%. This means that Gohealth is undervalued by 42.10%.
The range of the Intrinsic Value is 11.59 - 33.60 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 11.59 - 33.60 | 19.53 | 42.1% |
| DCF (Growth 10y) | 18.57 - 46.36 | 28.62 | 108.3% |
| DCF (EBITDA 5y) | 7.45 - 40.41 | 20.98 | 52.7% |
| DCF (EBITDA 10y) | 15.24 - 52.86 | 29.84 | 117.2% |
| Fair Value | -0.64 - -0.64 | -0.64 | -104.63% |
| P/E | (1.61) - (3.31) | (2.28) | -116.6% |
| EV/EBITDA | 9.74 - 103.35 | 39.80 | 189.6% |
| EPV | 101.41 - 167.09 | 134.25 | 877.0% |
| DDM - Stable | (0.58) - (1.45) | (1.01) | -107.4% |
| DDM - Multi | (1.12) - (2.46) | (1.57) | -111.4% |
| Market Cap (mil) | 316.16 |
| Beta | 0.21 |
| Outstanding shares (mil) | 23.01 |
| Enterprise Value (mil) | 762.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.12% |
| Cost of Debt | 8.44% |
| WACC | 9.81% |